Ziprasidone Hydrochloride Patent Expiration
Ziprasidone Hydrochloride is Used for managing symptoms of bipolar disorder, neuroleptic diseases, and psychosis. It was first introduced by Viatris Specialty Llc
Ziprasidone Hydrochloride Patents
Given below is the list of patents protecting Ziprasidone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Geodon | US7175855 | Ziprasidone suspension |
May 18, 2020
(Expired) | Pfizer Inc |
Geodon | US6150366 | Ziprasidone formulations |
May 27, 2019
(Expired) | Pfizer Inc |
Geodon | US6150366 | Ziprasidone formulations |
May 27, 2019
(Expired) | Viatris |
Geodon | US6245766 | Method of treating psychiatric conditions |
Dec 18, 2018
(Expired) | Pfizer Inc |
Geodon | US6245766 | Method of treating psychiatric conditions |
Dec 18, 2018
(Expired) | Viatris |
Geodon | US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
Sep 01, 2012
(Expired) | Pfizer Inc |
Geodon | US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
Sep 01, 2012
(Expired) | Viatris |
Ziprasidone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Ziprasidone Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Ziprasidone Hydrochloride. The first generic version for Ziprasidone Hydrochloride was by Lupin Pharmaceuticals Inc and was approved on Mar 2, 2012. And the latest generic version is by Zydus Lifesciences Ltd and was approved on Aug 22, 2017.
Given below is the list of companies who have filed for Ziprasidone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||
Canada |
| |||||||||||||
India |
|
2. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Dec 27, 2016 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Dec 27, 2016 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Dec 27, 2016 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Dec 27, 2016 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Sep 5, 2012 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Sep 5, 2012 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Sep 5, 2012 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Sep 5, 2012 |
4. DR REDDYS LABS INC
Dr Reddys Laboratories Inc has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
5. LUPIN PHARMS
Lupin Pharmaceuticals Inc has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 2012 |
6. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Feb 17, 2017 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Feb 17, 2017 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Feb 17, 2017 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Feb 17, 2017 |
7. MYLAN
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Discontinued | ORAL | N/A | Oct 10, 2013 |
EQ 40MG BASE | capsule | Discontinued | ORAL | N/A | Oct 10, 2013 |
EQ 60MG BASE | capsule | Discontinued | ORAL | N/A | Oct 10, 2013 |
EQ 80MG BASE | capsule | Discontinued | ORAL | N/A | Oct 10, 2013 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
| |||||||||||||||||
Canada |
| |||||||||||||||||
Ireland |
|
8. SANDOZ INC
Sandoz Inc has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2012 |
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2012 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2012 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Jun 1, 2012 |
Manufacturing Plant Locations New
Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
9. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 4 different strengths of generic version for Ziprasidone Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 20MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2017 |
EQ 40MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2017 |
EQ 60MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2017 |
EQ 80MG BASE | capsule | Prescription | ORAL | AB | Aug 22, 2017 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|